Our study also proves that PRMT5 promotes cell proliferation and EMT in human colorectal cancer via activation of the EGFR/Akt/GSK3β signaling axis, but not ERK1/2 or PTEN/mTOR signaling pathways, which is strongly linked to the PRMT5 enzyme activity. This evidence concerns the gene AKT1 and colorectal cancer.